New Research Published in ACS Infectious Diseases Examines Impact of Self-Assembly of Antimicrobial Peptoids on ESKAPE Bacterial Pathogens

Read the study here.

Maxwell is pleased to announce the ASAP (as soon as publishable) advance web publication of new research spearheaded by Maxwell scientific founder Prof. Annelise Barron in ACS Infectious Diseases. Barron is joined by co-authors Josefine Eilsø Nielsen; Morgan Ashley Alford; Deborah Bow Yue Yung; Natalia Molchanova; John A. Fortkort; Jennifer S. Lin; Robert E. W. Hancock; Gill Diamond; Håvard Jenssen; Daniel Pletzer; and Reidar Lund.

The journal article is titled how “Self-Assembly of Antimicrobial Peptoids Impacts Their Biological Effects on ESKAPE Bacterial Pathogens.” It represents the first report of self-assembling peptoid antibacterials with activity against in vivo biofilm-like infections relevant to clinical medicine. It considers the potential impact of antimicrobial peptoids on the multidrug-resistant ESKAPE pathogens, which are responsible for the majority of hospital-acquired infections. 

Read the abstract and full study below. 

Links

Previous
Previous

Maxwell Biosciences Awarded “Most Promising” 2022 Life Sciences Company in Texas Competition

Next
Next

Turning Nature’s Virus Fighters Into Powerful Drugs: Synthetic “Peptoids” to Cure Diseases